Complete Longitudinal Analyses of the Randomized, Placebo-controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor Following Imatinib Failure

PURPOSE: To analyze final long-term survival and clinical outcomes from the randomized phase III study of sunitinib in gastrointestinal stromal tumor (GIST) patients after imatinib failure; to assess correlative angiogenesis biomarkers with patient outcomes. EXPERIMENTAL DESIGN: Blinded sunitinib or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Demetri, George D., Garrett, Christopher R., Schöffski, Patrick, Shah, Manisha H., Verweij, Jaap, Leyvraz, Serge, Hurwitz, Herbert I., Pousa, Antonio Lopez, Le Cesne, Axel, Goldstein, David, Paz-Ares, Luis, Blay, Jean-Yves, McArthur, Grant A., Xu, Qiang (Casey), Huang, Xin, Harmon, Charles S., Tassell, Vanessa, Cohen, Darrel P., Casali, Paolo G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4030710/
https://ncbi.nlm.nih.gov/pubmed/22661587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-3005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados